Dauntless Pharmaceuticals Garners $12,000,000 Series A Financing

  • Feed Type
  • Date
    7/22/2015
  • Company Name
    Dauntless Pharmaceuticals
  • Mailing Address
    12520 High Bluff Drive San Diego, CA 92130 USA
  • Company Description
    We provide a creative way to advance programs that may not be funded within existing pharmaceutical research budgets. We license the asset from pharmaceutical and biotechnology companies, finance the development of the program, and provide a mechanism for the licensor to regain rights on clinical success.
  • Website
    http://www.dauntlessph.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $12,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The financing will fund the development of DP1038, a preclinical-stage drug for the potential treatment of endocrine cancers.
  • M&A Terms
  • Venture Investor
    Sofinnova Ventures